2025-08-20 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY citation citation_author em_admin em_vitrification _citation.country _citation.journal_abbrev _citation.journal_id_CSD _citation.journal_id_ISSN _citation.journal_volume _citation.page_first _citation.page_last _citation.pdbx_database_id_DOI _citation.pdbx_database_id_PubMed _citation.title _citation.year _citation_author.identifier_ORCID _citation_author.name _em_admin.last_update _em_vitrification.details _em_vitrification.instrument RCSB RCSB 2023-03-31 2024-05-29 2024-05-29 2025-08-20 Other private United States DDB1/CRBN in complex with ARV-471 and the ER ligand-binding domain Digianantonio K Drulyte I Gough S Bekes M Taylor I PROTAC, E3 ligase, ER, CRBN, PROTEIN BINDING Gough SM Flanagan JJ Teh J Andreoli M Rousseau E Pannone M Bookbinder M Willard R Davenport K Bortolon E Cadelina G Gordon D Pizzano J Macaluso J Soto L Corradi J Digianantonio K Drulyte I Morgan A Quinn C Bekes M Ferraro C Chen X Wang G Dong H Wang J Langley DR Houston J Gedrich R Taylor IC Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models. Clin.Cancer Res. US 30 3549 3563 2024 38819400 doi:10.1158/1078-0432.CCR-23-3465 1078-0432 EMDB EMD-40261 associated EM volume Ternary complex of DDB1/CRBN, ARV-471, and the ER ligand-binding domain Ternary complex of DDB1/CRBN, ARV-471, and the ER ligand-binding domain 0 Homo sapiens DDB1/CRBN 1 Homo sapiens Estrogen Receptor alpha ligand binding domain 1 Homo sapiens singleParticle particle 7.3 50.0 Hepes hepes 50.0 NaCl sodium chloride 1.0 TCEP ETHANE SPT LABTECH CHAMELEON FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 50.0 2.7 0.75 1.75 130000.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN TFS Selectris X 10
The microscope was equipped with an E-CFEG. Fringe-free imaging and aberration-free image shifts were used during data collection. Nominal pixel size for 130,000x - 0.96 A/px, calibrated - 0.933 A/px.
FEI FALCON IV (4k x 4k) 1 5321 6.32 50.5
Falcon 4i Detector operated in Electron-Event Representation mode was used to record the images.
 1 1081032 cryoSPARC 3.3.2 PHASE FLIPPING AND AMPLITUDE CORRECTION
ab initio cryoSPARC v3.3.2
 3.7 FSC 0.143 CUT-OFF 116673 MAXIMUM LIKELIHOOD cryoSPARC 3.3.2 MAXIMUM LIKELIHOOD cryoSPARC 3.3.2 3 cryoSPARC 3.3.2
3D Variability Analysis (with a local mask surrounding the CRBN-ER region and the resolution filtered to 10 A) was used to select the best subset of particles.
 emd_40261.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 240 240 240 0 0 0 240 240 240 335.88 335.88 335.88 90.0 90.0 90.0 X Y Z -1.0436109 1.9463576 0.0008971638 0.026171967 1.3995 1.3995 1.3995 0.08 AUTHOR Map filtered according to local resolution emd_40261_msk_1.map emd_40261_msk_2.map emd_40261_additional_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 240 240 240 0 0 0 240 240 240 335.88 335.88 335.88 90.0 90.0 90.0 X Y Z -0.26043537 0.66495955 -0.00028525162 0.015876956 1.3995 1.3995 1.3995 AUTHOR Unsharpened map emd_40261_additional_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 240 240 240 0 0 0 240 240 240 335.88 335.88 335.88 90.0 90.0 90.0 X Y Z -0.8766481 1.6423885 -0.00028525162 0.030689696 1.3995 1.3995 1.3995 AUTHOR Sharpened map emd_40261_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 240 240 240 0 0 0 240 240 240 335.88 335.88 335.88 90.0 90.0 90.0 X Y Z -0.3562854 0.82898253 0.00026218893 0.026562996 1.3995 1.3995 1.3995 AUTHOR Half map B emd_40261_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 240 240 240 0 0 0 240 240 240 335.88 335.88 335.88 90.0 90.0 90.0 X Y Z -0.37703785 0.8241071 0.00027923542 0.026504334 1.3995 1.3995 1.3995 AUTHOR Half map A